Access the full text.
Sign up today, get DeepDyve free for 14 days.
Rose Brueggeman, A. Noffke, L. Jampol (2002)
Resolution of punctate inner choroidopathy lesions with oral prednisone therapy.Archives of ophthalmology, 120 7
S Winterhalter, AM Joussen, U Pleyer, N Stübiger (2012)
Inflammatory choroidal neovascularisationsKlin Monatsbl Augenheilkde, 229
S. Pachydaki, F. Jakobiec, P. Bhat, L. Sobrin, N. Michaud, S. Seshan, D. D’Amico (2011)
Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumabJournal of Ophthalmic Inflammation and Infection, 2
Robert Watzke, A. Packer, J. Folk, William Benson, D. Burgess, R. Ober (1984)
Punctate inner choroidopathy.American journal of ophthalmology, 98 5
SI Pachydaki, A Jakobiec, P Bhat, L Sobrin, NA Michaud, SV Seshan, DJ D’Amico (2012)
Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathyJ Ophthal Inflamm Infect, 2
P. Rishi, Aditi Gupta, E. Rishi, B. Shah (2013)
Choroidal neovascularization in 36 eyes of children and adolescentsEye, 27
Han-guo Zhang, Zhe-li Liu, Peng Sun, Feng Gu (2012)
INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PUNCTATE INNER CHOROIDOPATHY: Results of a 1-year Prospective TrialRetina, 32
Theresa Leung, A. Moradi, Dianna Liu, Q. Nguyen, J. Dunn, Bryn Burkholder, N. Butler, Trucian Ostheimer, J. Thorne (2014)
CLINICAL FEATURES AND INCIDENCE RATE OF OCULAR COMPLICATIONS IN PUNCTATE INNER CHOROIDOPATHYRetina, 34
M. Amaro, C. Muccioli, M. Abreu (2007)
Ocular histoplasmosis-like syndrome: a report from a nonendemic area.Arquivos brasileiros de oftalmologia, 70 4
J. Campos, A. Campos, S. Mendes, A. Neves, D. Beselga, J. Sousa (2014)
Punctate Inner Choroidopathy: A Systematic ReviewMedical Hypothesis, Discovery and Innovation in Ophthalmology, 3
Adam Gerstenblith, J. Thorne, J. Thorne, L. Sobrin, D. Do, S. Shah, C. Foster, D. Jabs, D. Jabs, Q. Nguyen (2007)
Punctate inner choroidopathy: a survey analysis of 77 persons.Ophthalmology, 114 6
Ramin Schadlu, K. Blinder, Gaurav Shah, N. Holekamp, M. Thomas, M. Grand, Nicholas Engelbrecht, R. Apte, Daniel Joseph, Anita Prasad, Bradley Smith, A. Sheybani (2008)
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.American journal of ophthalmology, 145 5
B. Hohberger, M. Rudolph, A. Bergua (2015)
Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive TherapyCase Reports in Ophthalmology, 6
S. Mangat, Balasubramanian Ramasamy, S. Prasad, G. Walters, M. Mohammed, M. Mckibbin (2011)
Resolution of Choroidal Neovascularization Secondary to Punctate Inner Choroidopathy (PIC) with Intravitreal Anti-VEGF Agents: A Case SeriesSeminars in Ophthalmology, 26
R. Watzke, M. Klein, M. Wener (1998)
HISTOPLASMOSIS‐LIKE CHOROIDITIS IN A NONENDEMIC AREA:The Northwest United StatesRetina, 18
S. Chatterjee, J. Gibson (2003)
Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathyBritish Journal of Ophthalmology, 87
Rocio Diaz, Eric Sigler, M. Rafieetary, J. Calzada (2015)
Ocular histoplasmosis syndrome.Survey of ophthalmology, 60 4
R. Essex, J. Wong, S. Fraser-Bell, J. Sandbach, A. Tufail, A. Bird, J. Dowler (2010)
Punctate inner choroidopathy: clinical features and outcomes.Archives of ophthalmology, 128 8
A. Mansour, F. Mackensen, J. Arevalo, F. Ziemssen, P. Mahendradas, A. Mehio-Sibai, N. Hrisomalos, T. Lai, D. Dodwell, W. Chan, T. Ness, A. Banker, Sivakami Pai, M. Berrocal, R. Tohme, A. Heiligenhaus, Z. Bashshur, M. Khairallah, K. Salem, Frank Hrisomalos, Matthew Wood, W. Heriot, A. Adán, Atul Kumar, L. Lim, A. Hall, M. Becker (2008)
Intravitreal bevacizumab in inflammatory ocular neovascularization.American journal of ophthalmology, 146 3
R. Spaide (1999)
Choroidal neovascularization in younger patients.Current opinion in ophthalmology, 10 3
R. Amer, N. Lois (2011)
Punctate inner choroidopathy.Survey of ophthalmology, 56 1
S Weiss, R Winter, MW Meyer (2012)
Punctate inner choroidopathy—Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up controlOphthalmologe, 109
S. Winterhalter, A. Joussen, U. Pleyer, N. Stübiger (2012)
Inflammatorische choroidale NeovaskularisationenKlin Monatsbl Augenheilkd, 229
P. Neri, M. Manoni, Cinzia Fortuna, M. Lettieri, C. Mariotti, A. Giovannini (2010)
Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: interventional case seriesInternational Ophthalmology, 30
Timothy Olsen, A. Capone, P. Sternberg, H. Grossniklaus, Daniel Martin, T. Aaberg (1996)
Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings.Ophthalmology, 103 12
J. Campos, A. Campos, D. Beselga, S. Mendes, A. Neves, J.P. Sousa (2013)
Punctate Inner Choroidopathy: A Clinical Case ReportCase Reports in Ophthalmology, 4
J. Arevalo, A. Adán, M. Berrocal, Juan Espinoza, M. Maia, Lihteh Wu, J. Roca, H. Quiroz-Mercado, J. Ruiz-Moreno, Martin Serrano (2011)
INTRAVITREAL BEVACIZUMAB FOR INFLAMMATORY CHOROIDAL NEOVASCULARIZATION: Results from the Pan-American Collaborative Retina Study Group at 24 MonthsRetina, 31
U. Vossmerbaeumer, U. Spandau, Stefan Baltz, A. Wickenhaeuser, J. Jonas (2008)
Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathyClinical & Experimental Ophthalmology, 36
Jeremiah Brown, J. Folk, Chittaranjan Reddy, Alan Kimura (1996)
Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome.Ophthalmology, 103 7
W. Chan, T. Lai, D. Liu, D. Lam (2007)
Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.American journal of ophthalmology, 143 6
D. Weiß, R. Winter, M. Meyer (2012)
PIC-Syndrom – Visusverbesserung nach Anti-VEGF- und photodynamischer TherapieDer Ophthalmologe, 109
V. Menezo, F. Cuthbertson, S. Downes (2010)
POSITIVE RESPONSE TO INTRAVITREAL RANIBIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PUNCTATE INNER CHOROIDOPATHYRetina, 30
Â. Carneiro, Rufino Silva, M. Veludo, Augusto Barbosa, J. Ruiz-Moreno, M. Falcão, E. Brandão, F. Falcão-Reis (2010)
Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological MyopiaOphthalmologica, 225
K. Patel, Andrea Birnbaum, H. Tessler, D. Goldstein (2010)
PRESENTATION AND OUTCOME OF PATIENTS WITH PUNCTATE INNER CHOROIDOPATHY AT A TERTIARY REFERRAL CENTERRetina, 31
J. Wachtlin, H. Heimann, T. Behme, M. Foerster (2003)
Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseasesGraefe's Archive for Clinical and Experimental Ophthalmology, 241
Int Ophthalmol (2018) 38:923–931 https://doi.org/10.1007/s10792-017-0536-0 ORIGINAL PAPER Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy . . . T. Barth F. Zeman H. Helbig M.-A. Gamulescu Received: 29 December 2016 / Accepted: 10 April 2017 / Published online: 19 April 2017 Springer Science+Business Media Dordrecht 2017 Abstract Keywords Choroidal neovascularization Punctate Purpose To assess the outcome of patients with inner choroidopathy Intravitreal antiangiogenic choroidal neovascularization (CNV) secondary to therapy Anti-VEGF (vascular endothelial growth punctate inner choroidopathy (PIC) receiving intrav- factor) itreal anti-VEGF (vascular endothelial growth factor) injections. Methods Sixteen eyes of 16 patients diagnosed with Introduction CNV secondary to PIC were retrospectively assessed. Punctate inner choroidopathy (PIC) is a rare, idio- Results Eleven women and five men with a mean age of 35 years (SD 11, range 16–56 years) received pathic chorioretinopathy that usually affects young and healthy myopic women of Caucasian origin [1, 2]. intravitreal anti-VEGF for PIC-related CNV. On average, 3.5 injections (SD 2.7, range 1–9) were given It is defined by the occurrence of multifocal small yellowish white lesions of retinal pigment epithelium per eye. Thirteen eyes were treated with bevacizumab, two eyes with ranibizumab and one eye received both
International Ophthalmology – Springer Journals
Published: Apr 19, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.